Dimerix

Dimerix Debt/Market Cap

The Debt to Market Capitalization Ratio of Dimerix (DXB.AX) as of Oct 19, 2026 is 0.08 %. In the previous year, Debt to Market Capitalization Ratio was 0.03 % — a change of 138.09% (higher).

Debt/Market Cap

0.08 %

YoY

138.09%

Last updated:

Debt to Market Capitalization Ratio of Dimerix is 2026 0.08 % . Debt to Market Capitalization Ratio of Dimerix was 2025 0.03 % . It decreases by 138.09% higher compared to the previous year.

The Dimerix Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2019
0.37 AUD
Jan 1, 2020
0.36 AUD
Jan 1, 2021
1.71 AUD
Jan 1, 2022
0.02 AUD
Jan 1, 2023
2.00 AUD
Jan 1, 2024
0.05 AUD
Jan 1, 2025
0.03 AUD
Jan 1, 2026
0.08 AUD
The Dimerix Debt/Market Cap history
YEARDebt/Market CapYoY
0.08 %+138.09%
0.03 %-34.88%
0.05 %-97.49%
2.00 %+8,050.33%
0.02 %-98.56%
1.71 %+382.55%
0.36 %-3.55%
0.37 %—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Debt to Market Capitalization Ratio of Dimerix is 0.08 % in 2026.

Debt to Market Capitalization Ratio of Dimerix changed from 0.03 % to 0.08 %, representing a 138.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Dimerix since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Dimerix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Dimerix

All Key Metrics — Dimerix